Table 3.

Mean levels of prevalence of metabolic syndrome by gender. The BCOPS Study, 2004–2009.

Metabolic Syndrome Component	Component Cutpoint**	Prevalence						Mean (SD)*
		Men		Women		Overall		Men (n = 288)	Women (n = 102)
		n	%	n	%	n	%
Abominal Obesity		112	38.9	18	17.7	130	33.3
Waist Circumfrence, cm	≥102 Men, ≥88 Women							99.8 (11.3)	80.2 (11.6)
Elevated triglycerides		114	39.6	9	8.8	123	31.5
Triglycerides, mg/dL	≥150	110	38.2	9	8.8			156.1 (127.4)	90.0 (132.3)
Self-reported fibrates or nicotinic acid medication, %	Yes	6	2.1	1	1.0	7	1.8
Reduced HDL cholesterol		139	48.3	27	26.5	166	42.6
HDL cholesterol, mg/dL	<40 Men, <50 Women	138	47.9	27	26.5			41.9 (12.0)	58.4 (15.9)
Self-reported fibrates or nicotinic acid medication, %	Yes	6	2.1	1	1.0	7	1.8
Glucose intolerance		80	27.8	12	11.8	92	23.6
Fasting glucose, mg/dL	≥100	78	27.1	11	10.8			94.8 (14.2)	86.4 (8.5)
Self-reported diabetes medication, %	Yes	7	2.4	1	1.0	8	2.1
Hypertension		127	44.1	27	26.5	154	39.5
Systolic blood pressure, mmHg	≥130	68	23.6	18	17.7			122.6 (11.3)	116.9 (13.5)
Diastolic blood pressure, mmHg	≥85	78	27.1	17	16.7			79.0 (10.1)	74.8 (9.6)
Self-reported hypertension w/antihypertensive medication, %	Yes	45	15.6	7	6.9	52	13.3
Number of components								2.0 (1.4)	0.9 (1.1)
	0	47	16.3	50	49.0	97	24.9
	1	68	23.6	24	23.5	92	23.6
	2	78	27.1	19	18.6	97	24.9
	3	48	16.7	6	5.9	54	13.9
	4	31	10.8	2	2.0	33	8.5
	5	16	5.6	1	1.0	17	4.4
	Prevalence (≥3)	95	33.0	9	8.8	104	26.7

^*Mean levels of the continuous variables were significantly different between men and women, p-value < 0.0001.

^**Component Cutpoint (Must meet ≥ 1 of the cutpoints per component).